WHO Consultation on Group B Streptococcus Vaccine Development: Report From a Meeting Held on 27-28 April 2016
This article, published in Vaccine, reports the outcome of a World Health Organization technical consultation that considered development pathways for group B Streptococcus (GBS) vaccines. The meeting discussed numerous topics, including disease pathophysiology; knoweldge gaps in global disease burden and serotype distribution; vaccine candidates in development; design considerations for Phase 3 trials; and policy recommendations and pathways to licensure. The authors note that efforts to address gaps in each of these areas are needed; in particular, more work is required to understand the global disease burden of GBS-associated stillbirths.
Author: Kobayashi M, Schrag SJ, Alderson MR, et al.
» Visit web page (English)
(Located at www.sciencedirect.com)
Citation: Kobayashi M, Schrag SJ, Alderson MR, et al. WHO Consultation on Group B Streptococcus Vaccine Development: Report From a Meeting Held on 27-28 April 2016. Vaccine. 2016.Early Online Publication.
Resource types: Peer-reviewed journal
Diseases/vaccines: Group B Streptococcus (GBS)